.5 minute read
A panel of vaccine experts endorsed a low-dose Pfizer vaccine shot for children ages 5-11. Next, the Food and Drug Administration (FDA) must decide if they agree with the endorsement.
This announcement could potentially affect 28 million children. And it comes at a time when some school districts have already announced vaccination mandates among eligible students.
The FDA is expected to accept the endorsement within days. After that, the Centers for Disease Control (CDC) will make a final decision. If the CDC agrees with the FDA, shots could become available immediately.
Download the bulletin for more details.
This blog is intended to be a compilation of information and resources pulled from federal, state, and local agencies. This is not intended to be legal advice. For up to the minute information and guidance on COVID-19, please follow the guidelines of the Centers for Disease Control and Prevention (CDC) and your local health organizations.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
